Differential transformation capacity of Src family kinases during the initiation of prostate cancer. - Wikidata - wikimedia - TriplyDB

Differential transformation capacity of Src family kinases during the initiation of prostate cancer.

Differential transformation capacity of Src family kinases during the initiation of prostate cancer.

http://www.wikidata.org/entity/Q34835580

about

Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinases SRC: marker or actor in prostate cancer aggressiveness CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.Engineered kinase activation reveals unique morphodynamic phenotypes and associated trafficking for Src family isoforms.Targeting protein lipidation in disease Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer C-Src and c-Yes are two unlikely partners of spermatogenesis and their roles in blood-testis barrier dynamics.Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer Molecular pathways and targets in prostate cancer Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy.Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression.Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.Oncogene-mediated alterations in chromatin conformation Functions of the Lyn tyrosine kinase in health and disease Src, p130Cas, and Mechanotransduction in Cancer Cells Investigation of the molecular mechanisms underlying metastasis in prostate cancer by gene expression profiling Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.The residue at position 5 of the N-terminal region of Src and Fyn modulates their myristoylation, palmitoylation, and membrane interactions.LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo.Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells.Src signaling pathways in prostate cancer.Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development.The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells.Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes.Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer.MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells.Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2.Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression.Myristoylation of Src kinase mediates Src-induced and high-fat diet-accelerated prostate tumor progression in mice.Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.CSF-1-induced Src signaling can instruct monocytic lineage choice.Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors.Emerging Roles of Fibroblast Growth Factor 10 in Cancer

P2860

Q26866135-B697F1D6-6364-4B76-9B4A-7AA499BE4573 Q27012541-867CF8A6-2517-4323-99AB-BE3628932FDF Q27348129-1BBE00F6-79D6-4946-A453-190C41F89B43 Q30009334-6AEAFAE6-8497-4844-AEFA-204A6DA3D4A0 Q30413212-49AB08A2-FCB2-4C99-A164-468827F1825E Q33426973-17A8666F-A215-48F5-9D24-890FC274AABD Q33643375-2609C032-EDD6-491E-8E28-6C4AD15AFC58 Q33966470-C4014FA1-3018-4FBB-B7E7-2AA19F9B5721 Q34364815-224BDBF8-4C75-46DA-B1B8-DD13F41286A1 Q34365632-49791194-9EED-445B-8EBC-60ABC8C1618A Q34926222-3562575E-E3C3-485C-A9C6-8AE23C7F6E27 Q35749654-4DCCD8DF-A291-4918-8EF1-A73CD184309E Q35832949-2EB76C6C-30D6-433C-8E06-70A06561861F Q36061468-778A57E2-70D3-408D-A084-3F064C8EFEFC Q36299576-2B5F84F6-F443-4F69-85D6-5EC5C51C3B02 Q36443416-9494029B-39ED-4774-80F3-ED3BE14F0E4B Q37108412-C8A42588-B2B4-43A8-9FEE-9231A28907AE Q37116160-E1C0D6B6-4898-468F-9B23-26C52A5E3BA2 Q37518131-4DC730A0-4880-4E03-9E7E-68D1CEF031D9 Q37696232-AAA6B421-FDAF-46A9-A2D2-5D108B69498A Q37718461-D73D0E8A-7F86-4FE3-80FD-9C6A5B3F2ECD Q37968256-F2408843-4ED9-4A6A-8473-B5A491377271 Q38180461-176593AF-B4C9-4496-9451-EE76F6959585 Q38187565-409DBDA1-AF48-49C2-A3FE-5DA3E218F500 Q38262816-FAEE15F8-E2D8-4E58-B150-53681D3D11B9 Q38433570-5B10D33F-BE32-45F2-9742-13E5B2B37EBE Q39366909-5E034A0C-9996-40F8-906D-ED2E20CAC634 Q39544175-0E15D414-7640-444E-84C5-F3EF464EB1D0 Q39984274-8F27DDB8-6202-4CB0-A48D-138198DD814B Q42028379-98474CFD-97B5-4703-8974-047C342D2856 Q42200676-461E28C7-BBBA-4E7F-A91C-A729FA3CAE10 Q47098074-00002586-45DA-451F-A602-0947397A28C8 Q47643576-ADF9ECA6-ADEB-40C7-BD62-9BFEAC22C667 Q47758380-EF1EC6F3-62F2-4E9D-9753-6676306BC76F Q48949605-9670290E-B202-4A33-9E0D-4218B5F64306 Q49997063-8D03EB11-3CD0-432B-B885-644943ED52A6 Q50457530-7DCEDE1B-A04A-4EAF-A060-E25571B4F3BE Q52726553-92D0ED80-C0D4-4818-B7ED-C34A29EFB4C4 Q55280808-B4DAA7A9-7D78-4553-882E-4DAA202ECD64 Q58566489-977D2D32-4CD1-4475-A41A-A3FA741EA71C

P2860

Differential transformation capacity of Src family kinases during the initiation of prostate cancer.

http://www.wikidata.org/entity/Q34835580

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Differential transformation ca ...... initiation of prostate cancer.

@ast

Differential transformation ca ...... initiation of prostate cancer.

@en

Differential transformation ca ...... initiation of prostate cancer.

@nl

type

label

Differential transformation ca ...... initiation of prostate cancer.

@ast

Differential transformation ca ...... initiation of prostate cancer.

@en

Differential transformation ca ...... initiation of prostate cancer.

@nl

prefLabel

Differential transformation ca ...... initiation of prostate cancer.

@ast

Differential transformation ca ...... initiation of prostate cancer.

@en

Differential transformation ca ...... initiation of prostate cancer.

@nl

P1433

Q34835580-19C57FC6-062C-48DF-A584-AC4AFD14C236

P1476

Q34835580-8A509379-688E-41EE-8FF5-7C7C883C5EE8

P2093

Q34835580-00D43463-9B60-4991-BFC0-D356594FD0A9

Q34835580-0F24D420-20A1-46F1-A816-D4F07B593485

Q34835580-25FC6680-7299-4BBC-963C-7FCB85975274

Q34835580-60009663-7CE9-4A1C-98AC-B1483C59A3CD

Q34835580-BE65AF45-D094-41A6-8C11-8AF8CC39CEB6

Q34835580-FAD14A8E-9DF8-4F8D-8A1C-25843A006C5E

P2860

Q34835580-1244D7F2-9DEA-4903-9E32-560875F898E4

Q34835580-1D1D0B02-1262-40F4-BAD4-440C8DA043D5

Q34835580-374735F2-B389-4E1C-A6A4-2B3ECB59527A

Q34835580-3E037E54-9BCC-47B2-BB33-5BEF86EDECE4

Q34835580-40B7C83F-6D53-4492-B512-F86F3028B2FA

Q34835580-4766A75C-508C-461D-9357-4553038B190C

Q34835580-487DC3FA-8ECB-40C1-B657-6E459593EDAC

Q34835580-529C996C-0A02-470B-8B08-8EEDD7EC2D5E

Q34835580-59D93A7C-BF76-48EF-93C2-736549155E4D

Q34835580-5BB77474-2C0C-41F6-BF52-6F7C86616881

P304

Q34835580-FF010645-63FD-4F05-BDC2-8FB987CE0855

P31

Q34835580-B560CCAB-15DC-46B5-BD38-267723CC2E10

P356

Q34835580-D83DFA08-06D7-4BAC-B400-107C966B78CC

P407

Q34835580-5A3301F0-4214-4325-91CC-5FB49889EA27

P433

Q34835580-B1F7C43C-AC57-4B70-86EE-55C8CF18C658

P478

Q34835580-45A1AF22-706C-43F9-BCEA-4C2A7CB4D9DD

P577

Q34835580-33164FFA-8E1C-437C-B3BD-1EDF3D16E66D

P5875

Q34835580-432C5D99-2A25-4A79-90F2-FC439ADD5794

P698

Q34835580-C2F51E51-A9CE-4DBF-AC0C-C1426F76B57D

P932

Q34835580-3984C360-F763-4E88-B0DF-8C3DA113B0EE

P356

PNAS.1103904108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Differential transformation ca ...... initiation of prostate cancer.

@en

P2093

Clifford A Lowell

http://www.w3.org/2001/XMLSchema#string

Daniel A Smith

http://www.w3.org/2001/XMLSchema#string

Houjian Cai

http://www.w3.org/2001/XMLSchema#string

Jonathan A Cooper

http://www.w3.org/2001/XMLSchema#string

Owen N Witte

http://www.w3.org/2001/XMLSchema#string

Sanaz Memarzadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor

The hunting of the Src

Myristylation and palmitylation of Src family members: the fats of the matter

FYN is overexpressed in human prostate cancer

Src kinase activity is essential for osteoclast function

Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice

Stromal fibroblasts in cancer initiation and progression

Regulation, substrates and functions of src

The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.

P304

6579-6584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1103904108

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50999589

http://www.w3.org/2001/XMLSchema#string

P698

21464326

http://www.w3.org/2001/XMLSchema#string

P932

3080985

http://www.w3.org/2001/XMLSchema#string